Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CBRE Group | CBRE | Jan 16, 2025 | 134.75 | +2.63 |
CCC Intelligent Solutions | CCCS | Jan 16, 2025 | 11.11 | +1.00 |
CCSC Technology International A | CCTG | Jan 16, 2025 | 1.70 | 0.00 |
CDT Environmental Technology Investment Holdings | CDTG | Jan 16, 2025 | 1.25 | -5.25 |
CDW | CDW | Jan 16, 2025 | 187.79 | +0.18 |
CEA Industries | CEAD | Jan 16, 2025 | 7.75 | +0.26 |
CECO Environmental | CECO | Jan 16, 2025 | 32.15 | +1.01 |
Cedar Realty Trust B Pref | CDR-B | Jan 16, 2025 | 15.45 | -0.99 |
Cedar Realty Trust C Pref | CDR-C | Jan 16, 2025 | 14.72 | -1.07 |
CEF Income Composite Powershares | PCEF | Jan 16, 2025 | 19.52 | 0.00 |
Cel-Sci | CVM | Jan 16, 2025 | 0.40 | -2.64 |
Celanese | CE | Jan 16, 2025 | 71.90 | +1.25 |
Celcuity | CELC | Jan 16, 2025 | 11.25 | +0.18 |
Celestica | CLS | Jan 16, 2025 | 110.72 | +3.00 |
Celldex Therapeutics | CLDX | Jan 16, 2025 | 22.76 | +0.62 |
Cellebrite | CLBT | Jan 16, 2025 | 22.98 | +0.31 |
Cellectar Biosciences | CLRB | Jan 16, 2025 | 0.24 | -2.38 |
Cellectis ADR | CLLS | Jan 16, 2025 | 1.51 | -7.93 |
Celsius | CELH | Jan 16, 2025 | 27.59 | +1.06 |
Celularity A | CELU | Jan 16, 2025 | 2.20 | +2.80 |
Cementos Pacasmayo ADR | CPAC | Jan 16, 2025 | 5.70 | -1.38 |
CEMEX ADR | CX | Jan 16, 2025 | 5.45 | -1.98 |
Cemtrex | CETX | Jan 16, 2025 | 3.08 | -0.32 |
Cencora | COR | Jan 16, 2025 | 240.89 | +1.35 |
Cenntro | CENN | Jan 16, 2025 | 1.21 | +0.83 |
Cenovus Energy | CVE | Jan 16, 2025 | 14.84 | -1.85 |
Centene | CNC | Jan 16, 2025 | 62.87 | -0.44 |
CenterPoint Energy | CNP | Jan 16, 2025 | 32.80 | +2.92 |
Centerra Gold | CGAU | Jan 16, 2025 | 5.84 | +0.52 |
Centerspace | CSR-C | Jan 16, 2025 | 24.98 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.